Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Nutex Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Nutex Health's profit margin for the twelve months ending Sep 30, 2026 was 20.7%. For fiscal 2025 it was 8.1%, against 10.9% the year before. The highest annual figure on record is 2512.6% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.1% | −2.8 |
| FY2024 | Dec 31, 2024 | 10.9% | +29.3 |
| FY2023 | Dec 31, 2023 | -18.5% | +175.2 |
| FY2022 | Dec 31, 2022 | -193.7% | −233.7 |
| FY2021 | Dec 31, 2021 | 40.0% | +1.3 |
| FY2020 | Dec 31, 2020 | 38.7% | +559.5 |
| FY2019 | Dec 31, 2019 | -520.8% | −451.3 |
| FY2018 | Dec 31, 2018 | -69.5% | −2582.1 |
| FY2017 | Dec 31, 2017 | 2512.6% | +2494.9 |
| FY2015 | Dec 31, 2015 | 17.7% | +81.7 |
| FY2014 | Dec 31, 2014 | -64.0% | −81.2 |
| FY2013 | Dec 31, 2013 | 17.1% | +119.0 |
| FY2012 | Dec 31, 2012 | -101.9% | −80.4 |
| FY2011 | Dec 31, 2011 | -21.5% | −39.6 |
| FY2010 | Dec 31, 2010 | 18.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 18.5% | −2.2 |
| Q2 FY2026 | Jun 30, 2026 | 31.2% | +38.5 |
| Q1 FY2026 | Mar 31, 2026 | 21.6% | +11.6 |
| Q4 FY2025 | Dec 31, 2025 | 7.8% | −16.1 |
| Q3 FY2025 | Sep 30, 2025 | 20.7% | +31.9 |
| Q2 FY2025 | Jun 30, 2025 | -7.3% | −6.8 |
| Q1 FY2025 | Mar 31, 2025 | 10.0% | +10.6 |
| Q4 FY2024 | Dec 31, 2024 | 23.9% | +69.3 |
| Q3 FY2024 | Sep 30, 2024 | -11.2% | −2.3 |
| Q2 FY2024 | Jun 30, 2024 | -0.5% | +5.4 |
| Q1 FY2024 | Mar 31, 2024 | -0.5% | +8.6 |
| Q4 FY2023 | Dec 31, 2023 | -45.4% | −17.9 |
| Q3 FY2023 | Sep 30, 2023 | -8.8% | +1442.8 |
| Q2 FY2023 | Jun 30, 2023 | -5.9% | +27.3 |
| Q1 FY2023 | Mar 31, 2023 | -9.1% | −36.2 |
| Q4 FY2022 | Dec 31, 2022 | -27.5% | +8.0 |
| Q3 FY2022 | Sep 30, 2022 | -1451.6% | −1514.8 |
| Q2 FY2022 | Jun 30, 2022 | -33.2% | −80.5 |
| Q1 FY2022 | Mar 31, 2022 | 27.1% | +249.7 |
| Q4 FY2021 | Dec 31, 2021 | -35.4% | −73.9 |
| Q3 FY2021 | Sep 30, 2021 | 63.1% | −438.6 |
| Q2 FY2021 | Jun 30, 2021 | 47.2% | −12.8 |
| Q1 FY2021 | Mar 31, 2021 | -222.6% | +18.5 |
| Q4 FY2020 | Dec 31, 2020 | 38.5% | +750.1 |
| Q3 FY2020 | Sep 30, 2020 | 501.7% | +942.4 |
| Q2 FY2020 | Jun 30, 2020 | 60.0% | +426.2 |
| Q1 FY2020 | Mar 31, 2020 | -241.1% | +215.3 |
| Q4 FY2019 | Dec 31, 2019 | -711.5% | −786.0 |
| Q3 FY2019 | Sep 30, 2019 | -440.7% | +2254.0 |
| Q2 FY2019 | Jun 30, 2019 | -366.2% | +19125.1 |
| Q1 FY2019 | Mar 31, 2019 | -456.4% | +14095.9 |
| Q4 FY2018 | Dec 31, 2018 | 74.4% | +35923.2 |
| Q3 FY2018 | Sep 30, 2018 | -2694.7% | +2870.2 |
| Q2 FY2018 | Jun 30, 2018 | -19491.3% | – |
| Q1 FY2018 | Mar 31, 2018 | -14552.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -35848.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -5564.9% | – |
See a number that looks wrong?